Page Content
HANC facilitates the trans-NIH institute, cross-network Behavioral Science Working Group (BSWG). The BSWG’s overarching goal is to ensure that the DAIDS clinical trials networks benefit from state-of-the-science methods and procedures that optimize adherence to product and risk reduction counseling and minimize the risk of confounding user and product failures. Further, the BSWG endeavors to maximize fiscal and scientific resources, reduce redundancies, improve cross-network communication and collaboration, and ensure that the best quality behavioral science is integrated into clinical trials.
Page Content 2
“Prevention Adherence in the DAIDS HIV Clinical Trial Networks” Meeting
The 2008 meeting objectives were to: facilitate cross-network communication and collaboration, review the relevant adherence literature, explore lessons for improving adherence measurement and counseling, identify a prevention adherence research agenda for network trials. The BSWG was formed as a result of this meeting.
More information